KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) EBT (2016 - 2025)

Historic EBT for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $1.2 billion.

  • Cme's EBT rose 0.85% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 billion, marking a year-over-year increase of 894.0%. This contributed to the annual value of $4.5 billion for FY2024, which is 933.65% up from last year.
  • As of Q3 2025, Cme's EBT stood at $1.2 billion, which was up 0.85% from $1.3 billion recorded in Q2 2025.
  • Cme's EBT's 5-year high stood at $1.3 billion during Q2 2025, with a 5-year trough of $726.1 million in Q2 2021.
  • Moreover, its 5-year median value for EBT was $1.0 billion (2023), whereas its average is $1.0 billion.
  • Examining YoY changes over the last 5 years, Cme's EBT showed a top increase of 10426.84% in 2021 and a maximum decrease of 2395.63% in 2021.
  • Over the past 5 years, Cme's EBT (Quarter) stood at $799.3 million in 2021, then rose by 3.5% to $827.3 million in 2022, then grew by 21.6% to $1.0 billion in 2023, then grew by 9.01% to $1.1 billion in 2024, then rose by 7.33% to $1.2 billion in 2025.
  • Its EBT stands at $1.2 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.2 billion for Q1 2025.